Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Mynaric AG (MYNA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
Bronstein, Gewirtz & Grossman, is investigating potential claims against Mynaric AG (NASDAQ:MYNA) on behalf of its shareholders. The investigation follows Mynaric's reduced 2024 financial guidance announced on August 20, 2024, which the company attributed to production challenges, lower yields, and component shortages. This news led to a drop in Mynaric's stock price.
Investors who purchased Mynaric securities are encouraged to participate in the investigation. The law firm is offering its services on a contingency fee basis, meaning fees will only be charged if the case is successful. Bronstein, Gewirtz & Grossman has a track record of recovering significant sums for investors in securities fraud class actions and shareholder derivative suits.
Bronstein, Gewirtz & Grossman sta indagando su potenziali pretese contro Mynaric AG (NASDAQ:MYNA) per conto dei suoi azionisti. L'indagine segue la riduzione delle previsioni finanziarie 2024 annunciata il 20 agosto 2024, che l'azienda ha attribuito a sfide produttive, rendimenti inferiori e carenze di componenti. Questa notizia ha portato a un calo del prezzo delle azioni di Mynaric.
Gli investitori che hanno acquistato titoli Mynaric sono incoraggiati a partecipare all'indagine. Lo studio legale offre i suoi servizi su base di tariffa contingente, il che significa che le spese saranno addebitate solo se il caso avrà successo. Bronstein, Gewirtz & Grossman ha un comprovato track record nel recuperare somme significative per gli investitori in azioni di frode sui titoli e cause derivate dagli azionisti.
Bronstein, Gewirtz & Grossman está investigando posibles reclamaciones contra Mynaric AG (NASDAQ:MYNA) en nombre de sus accionistas. La investigación sigue a la reducción de las previsiones financieras para 2024 anunciada el 20 de agosto de 2024, que la empresa atribuyó a desafíos de producción, menores rendimientos y escasez de componentes. Esta noticia provocó un descenso en el precio de las acciones de Mynaric.
Se anima a los inversores que compraron valores de Mynaric a participar en la investigación. El bufete ofrece sus servicios en una base de honorarios de contingencia, lo que significa que se cobrarán honorarios solo si el caso tiene éxito. Bronstein, Gewirtz & Grossman tiene un historial de recuperación de sumas significativas para los inversores en acciones de fraude de valores y demandas derivadas de los accionistas.
브론슈타인, 게위르츠 & 그로스만 미나릭 AG (NASDAQ:MYNA)에 대한 잠재적 청구를 조사하고 있습니다 주주를 대신하여. 이 조사는 미나릭이 2024년 재무 전망을 하향 조정한 후 2024년 8월 20일 발표한 조치로, 회사는 생산 문제, 낮은 수익률 및 부품 부족을 원인으로 꼽았습니다. 이 소식은 미나릭의 주가 하락을 초래했습니다.
미나릭 증권을 구매한 투자자들은 조사에 참여할 것을 권장합니다. 로펌은 성과 수수료 기반으로 서비스를 제공합니다, 즉 사건이 성공할 경우에만 수수료가 청구됩니다. 브론슈타인, 게위르츠 & 그로스만은 증권 사기 집단 소송 및 주주 파생 소송에서 투자자에게 상당한 금액을 복구한 경험이 있습니다.
Bronstein, Gewirtz & Grossman est en train d'enquêter sur des revendications potentielles contre Mynaric AG (NASDAQ:MYNA) au nom de ses actionnaires. L'enquête fait suite à l'abaissement des prévisions financières pour 2024 annoncé le 20 août 2024, que l'entreprise a attribué à des défis de production, des rendements plus faibles et des pénuries de composants. Cette nouvelle a entraîné une baisse du prix de l'action de Mynaric.
Les investisseurs ayant acheté des titres Mynaric sont encouragés à participer à l'enquête. Le cabinet d'avocats propose ses services sur une base de frais de succès, ce qui signifie que des frais ne seront facturés que si l'affaire est couronnée de succès. Bronstein, Gewirtz & Grossman a un bilan éprouvé en matière de récupération de sommes importantes pour les investisseurs dans des actions en justice pour fraude aux valeurs mobilières et des recours collectifs dérivés des actionnaires.
Bronstein, Gewirtz & Grossman untersucht mögliche Ansprüche gegen Mynaric AG (NASDAQ:MYNA) im Namen seiner Aktionäre. Die Untersuchung folgt auf die herabgesetzte finanzielle Unternehmensprognose für 2024, die am 20. August 2024 angekündigt wurde und die das Unternehmen auf Produktionsschwierigkeiten, geringere Erträge und Komponentenengpässe zurückführt. Diese Nachricht führte zu einem Rückgang des Aktienkurses von Mynaric.
Investoren, die Wertpapiere von Mynaric erworben haben, werden ermutigt, an der Untersuchung teilzunehmen. Die Kanzlei bietet ihre Leistungen auf Erfolgsbasis an, das bedeutet, dass Gebühren nur dann erhoben werden, wenn der Fall erfolgreich ist. Bronstein, Gewirtz & Grossman hat eine Erfolgsbilanz bei der Rückforderung erheblicher Beträge für Investoren in Wertpapierbetrugs-Klagen und Aktionärsklagen.
- None.
- Mynaric reduced its 2024 financial guidance
- Production challenges reported by the company
- Lower yields and component shortages affecting performance
- Stock price dropped following the announcement
- Potential legal claims being investigated against the company
The investigation into Mynaric AG (MYNA) by Bronstein, Gewirtz & Grossman, signals potential legal troubles for the company. The firm's focus on production challenges, lower yields and component shortages that led to reduced 2024 financial guidance suggests possible mismanagement or failure to disclose material information. This could lead to a class action lawsuit if evidence of wrongdoing is found.
Investors should be cautious, as legal proceedings can be costly and time-consuming, potentially impacting
The reduction in Mynaric's 2024 financial guidance is a significant red flag for investors. Production challenges, especially in a high-tech industry like satellite communications, can have severe implications on a company's financial health. The mention of lower yields and component shortages suggests supply chain issues that could persist, affecting future revenues and profitability.
The stock price drop following this announcement indicates a loss of investor confidence. While the exact figures aren't provided, such guidance reductions often lead to
NEW YORK CITY, NY / ACCESSWIRE / August 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mynaric AG ("Mynaric" or "the Company") (NASDAQ:MYNA). Investors who purchased Mynaric securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MYNA.
Investigation Details
On August 20, 2024, Mynaric reduced its 2024 financial guidance. The Company blamed the change on production challenges. The Company further blamed lower yields and component shortages for its lower performance. Following this news, Mynaric stock price dropped.
What's Next?
If you are aware of any facts relating to this investigation or purchased Mynaric securities, you can assist this investigation by visiting the firm's site: bgandg.com/MYNA. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on accesswire.com
FAQ
Why is Mynaric AG (MYNA) under investigation?
What caused Mynaric (MYNA) to reduce its 2024 financial guidance?
How did Mynaric's (MYNA) stock price react to the reduced guidance news?
What should Mynaric (MYNA) shareholders do regarding the investigation?
